About the Role
Parachute is building the clinical operations and real-world evidence function to turn its national biologics platform into a recruitment and biospecimen engine. This role will design, launch, and advise on building a multi-site observational registry from the ground up, owning the registry from blank page to enrollment.
Responsibilities
- Lead end-to-end registry design and author the registry protocol, charter, informed consent / authorization language, regulatory packets, data dictionary, etc.
- Lead consent and privacy strategy, defending the choice to the IRB and internal legal/privacy.
- Select and engage the central IRB (Advarra or WCG); negotiate the Master Services Agreement and reliance framework.
- Build and execute the site-activation playbook, including feasibility, qualification, site participation agreements, BAAs/DUAs, regulatory packets, and training.
- Select and configure the EDC/registry platform (REDCap, Castor, Medidata RWS, or equivalent); spec CRFs, edit checks, and query workflows.
- Stand up the eTMF (Veeva Vault, Florence, or structured equivalent) to DIA TMF Reference Model standards.
- Achieve First Subject In within 6–9 months of start.
Requirements
- 8+ years in RWE and/or registry programs and/or phase 4 experience.
- Designed and built at least one registry from the ground up, including registry design, protocol authoring, and regulatory/start-up documentation.
- Led at least one multi-site observational registry or post-marketing study from protocol through enrollment or has deep experience in phase 4 trials.
- Comfortable operating in a data-collection paradigm (observational registries) as distinct from running an interventional experiment.
- Working command of ICH E6(R3) GCP, 45 CFR 46 (Common Rule), HIPAA Privacy/Security, and 21 CFR Part 11.
- Authored or successfully defended an IRB waiver of consent / waiver of HIPAA authorization.
- Direct working experience with Advarra and/or WCG as central IRB.
- Hands-on with at least one EDC/registry platform (REDCap, Castor, Medidata Rave RWS, OpenClinica, Veeva CDMS).
- Built and negotiated site participation agreements and BAAs/DUAs at scale (10+ sites).
- Been through at least one FDA BIMO inspection or rigorous sponsor audit.
- Significant and direct experience interacting with FDA CBER.
- Academic or research-institution registry experience (e.g., investigator-initiated or epidemiologic registries), in addition to or alongside industry experience.
- Blood, transfusion medicine, hematology, or apheresis exposure.
- Working knowledge of AABB standards, donor eligibility (21 CFR 630), and blood establishment regulations.
- Experience interacting with FDA, and CBER in particular.
- Start-up or small-company operating experience.
- Familiarity with state privacy law overlays (CCPA/CPRA, WA MHMD, TX HB 300).
- CCRP, CCRA, RAC, or CIP certification.
- Experience with payer/HEOR-driven registries.
- Exposure to eConsent platforms (DocuSign Life Sciences, Medidata Patient Cloud, Castor eConsent).
Skills
- RWE
- Registry programs
- Phase 4 experience
- Registry design
- Protocol authoring
- Regulatory documentation
- Consent strategy
- Privacy strategy
- IRB interaction
- Site activation
- EDC/registry platform configuration
- eTMF management
- ICH E6(R3) GCP
- 45 CFR 46 (Common Rule)
- HIPAA Privacy/Security
- 21 CFR Part 11
- Central IRB (Advarra/WCG)
- Site participation agreements
- BAAs/DUAs
- FDA BIMO inspection
- Sponsor audit
- FDA CBER interaction
- AABB standards
- Donor eligibility
- Blood establishment regulations
- Start-up operations
- State privacy laws (CCPA/CPRA, WA MHMD, TX HB 300)
- CCRP
- CCRA
- RAC
- CIP certification
- Payer/HEOR registries
- eConsent platforms
Location
- Austin, TX
Work Type
- Full Time
- In-house
- Sponsor-side
Experience Level
- 8+ years
About the Company
- Parachute operates a national, software-enabled biologics platform with 55 plasma and blood collection centers across 20 states, serving over 500k donors.
- The company's footprint serves as the foundation for a longitudinally-engaged donor population that can power the next generation of blood-based clinical research.
- Parachute is building the clinical operations and real-world evidence function that turns that network into a recruitment and biospecimen engine.
